Tribio Anti-IL-17 & TNF-alpha Bispecific Antibody (TBS10503)

Description

Description: Trbio Anti-IL-17 & TNF-alpha Bispecific Antibody targets IL-17 and TNF-α, two key pro-inflammatory cytokines involved in autoimmune and inflammatory signaling. It is mainly used in preclinical immunology and disease models (such as arthritis and other chronic inflammatory conditions) to study combined cytokine blockade and its effects on immune-driven inflammation.

Applications: ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Species reactivity: Human

Host species: Human

Target: Interleukin-17A, IL-17, IL-17A, Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8, IL17A, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a, Tumor necrosis factor membrane form, N-terminal fragment, NTF, Intracellular domain 1, ICD1, Intracellular domain 2, ICD2, C-domain 1, C-domain 2, Tumor necrosis factor soluble form, TNF

Isotype: IgG-VHH

Accession/UniProt: Q16552 & P01375

Concentration: 3 mg/ml

Purity: >95%

Formulation: Liquid

Storage buffer: 0.01M PBS, pH 7.4

Purification: Protein A/G purified from cell culture supernatant.

Clonality: Monoclonal

Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.

Research use only.

Additional information